Shortening time to market through digital twins.
This document summarizes a case where Accenture worked with a major materials manufacturing client to shorten the time to market by utilizing digital twins. The client was conducting trial runs on actual machines before mass production, which led to a reliance on specific expertise for verification know-how, dependence on actual machines and trial runs, and verification data confined to specific locations, resulting in prolonged startup times. Accenture provided support focusing on three key areas: "building digital twins," "establishing decision-making processes," and "calculating return on investment (planning and conceptualization)." By conducting pre-mass production operations through simulation and designing verification items and acceptance criteria for pre-mass production trial runs, the process was transformed to allow decision-making to be replicated without experts. As a result, the mass production startup period was shortened from 9 months to 3 months, a reduction of approximately 65%. The expected benefits include a 5.5% increase in total sales per product lifecycle and a 50% cost reduction through operation without actual machines during trial runs.
Inquire About This Product
basic information
Building a digital twin environment Simulation of pre-mass production trial runs (verification without physical equipment) Design of verification items and acceptance criteria for pre-mass production trial runs Simulation of the effect of AI on reducing time to market Verification of optimal market launch timing
Price range
Delivery Time
Applications/Examples of results
【Purpose】 Shortening the mass production startup period for new products Improving the efficiency of trial operations during design changes and reducing production downtime Standardizing verification know-how and expanding it to other locations 【Achievements】 Reduced mass production startup period from 9 months to 3 months, approximately a 65% reduction Increased total sales amount per product lifecycle by 5.5% Achieved a 50% cost reduction through operation without actual equipment during trial runs
catalog（1）
Download All Catalogs
Company information
Accenture transforms change into power, providing 360-degree value to customers, employees, shareholders, partner companies, and society. We support Bristol Myers Squibb by leveraging generative AI and automation to accelerate clinical trials and streamline drug development. We consolidate our full capabilities as a reinvention service to solve the most challenging problems. We guide enterprise transformation to be executed on a larger scale and with greater impact.
